We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

News · November 24, 2020

AAO 2020: Pooled Analysis of ARTEMIS 1 and 2 Identifies Risks Factors for Requiring Rescue Medication After Bimatoprost Implant for Open-Angle Glaucoma

Currently, only single implants of bimatoprost 10 mcg are FDA approved

PracticeUpdate Editorial Team


Further Reading